Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 1.10.2025TS Pharma s.r.o. (TPH-1)43044Tarka 180 mg/2 mg tablety (tbl flm 28x180 mg/2 mg (blis.PVC/PVDC/Al))2.10.2025O
 1.10.2025Viatris Limited (VIM)3606ATramadol Viatris 100 mg (tbl plg 30x100 mg (blis.Al/PVC/PE/PVDC))1.10.2025O
 1.10.2025Viatris Limited (VIM)35237Alfuzosin Viatris 10 mg (tbl plg 90x10 mg (blis.PVC/PVDC/Al))6.10.2025O
 1.10.2025Egis Pharmaceuticals PLC (EGI)0684EEgoropal 75 mg (sus iph 1x75 mg (striek.inj.napln.+2 ihly))1.10.2025O
 1.10.2025Chiesi Farmaceutici S.p.A. (CHS)4135EFilsuvez gél (gel 10x23,4 mg (tuba biela Al))6.10.2025U
 1.10.2025STADA Arzneimittel AG (STD)8305EPerindopril/Indapamid/Amlodipín STADA 10 mg/2,5 mg/5 mg (tbl flm 30x10 mg/2,5 mg/5 mg (blis.Al/Al))30.9.2025U
 1.10.2025STADA Arzneimittel AG (STD)8297EPerindopril/Indapamid/Amlodipín STADA 5 mg/1,25 mg/5 mg (tbl flm 30x5 mg/1,25 mg/5 mg (blis.Al/Al))30.9.2025U
 30.9.2025Noridem Enterprises Ltd. (NID)2905EAciclovir Noridem 500 mg prášok na infúzny roztok (plv ifo 10x500 mg (liek.inj.skl.))1.8.2025U
 30.9.2025Teva B.V. (TEV-NL-4)35947Betahistin Actavis 16 mg (tbl 60x16 mg)30.9.2025O
 30.9.2025Teva B.V. (TEV-NL-4)35950Betahistin Actavis 8 mg (tbl 100x8 mg)30.9.2025O
 30.9.2025TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)21302Atorvastatin Teva Pharma 80 mg (tbl flm 28x80 mg (blis.Al/Al))1.12.2025Z
 30.9.2025Noridem Enterprises Ltd. (NID)6921DBupivacaine Noridem 5 mg/ml injekčný roztok (sol inj 10x20ml/100 mg (amp.PP))1.10.2025R
 30.9.2025Pfizer Europe MA EEIG (PFI-BE-3)1441EVYDURA 75 mg perorálny lyofilizát (lyo por 16x1x75 mg (blis.PVC/OPA/Al) - jednotk.bal.))29.9.2025U
 30.9.2025Techdow Pharma Netherlands B.V. (TED)5907CInhixa 6 000 IU (60 mg)/0,6 ml injekčný roztok v naplnenej injekčnej striekačke (sol inj 10x0,6 ml/60 mg (striek.inj.napl.skl. s krytom ihly))24.9.2025U
 30.9.2025Techdow Pharma Netherlands B.V. (TED)5905CInhixa 4 000 IU (40 mg) /0,4 ml injekčný roztok v naplnenej injekčnej striekačke (sol inj 10x0,4 ml/40 mg (striek.inj.napl.skl. s krytom ihly))24.9.2025U

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)